Lower Costs, More Cures Act of 2019

Administrative law and regulatory procedures Administrative remedies Advisory bodies Appropriations Biological and life sciences Business records Cancer Chemistry Child health Civil actions and liability Competition and antitrust Congressional oversight Consumer affairs Corporate finance and management Cosmetics and personal care Department of Health and Human Services Digestive and metabolic diseases Drug safety, medical device, and laboratory regulation Drug therapy Executive agency funding and structure Federal Trade Commission (FTC) Food and Drug Administration (FDA) Fraud offenses and financial crimes Genetics Government information and archives Government studies and investigations Health Health care costs and insurance Health information and medical records Health personnel Health programs administration and funding Health technology, devices, supplies Home and outpatient care Hospital care Immunology and vaccination Income tax deductions Income tax exclusion Inflation and prices Intellectual property Intergovernmental relations Judicial review and appeals Licensing and registrations Manufacturing Marketing and advertising Medicaid Medical education Medical research Medical tests and diagnostic methods Medicare Office of the U.S. Trade Representative Prescription drugs Product development and innovation Public participation and lobbying Research and development Retail and wholesale trades State and local government operations Trade agreements and negotiations User charges and fees Women's health +56...